Phase I/II study of erlotinib combined with cisplatin and radiotherapy for locally advanced squamous cell carcinoma of the head and neck (SCCHN).

被引:0
|
作者
Herchenhorn, D.
Dias, F. L.
Ferreira, C. G.
Bezerra, M.
Fonseca, A. J.
Mora, P.
Pineda, R. M.
Fontao, K.
Knust, R. E.
Martins, R. G.
机构
[1] Inst Nacl Canc, Rio De Janeiro, Brazil
[2] Univ Washington, Seattle, WA 98195 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:298S / 298S
页数:1
相关论文
共 50 条
  • [21] Multicenter randomized phase II trial of combined radiotherapy and cisplatin with or without erlotinib in patients with locally advanced squamous cell carcinoma of the head and neck (SCCAHN): Preliminary toxicity results.
    Hayes, D. N.
    Raez, L. E.
    Sharma, A. K.
    Papagikos, M. A.
    Yunus, F.
    Parvathaneni, U.
    Eaton, K. D.
    Futran, N.
    Wallace, S. G.
    Martins, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [23] Induction Chemotherapy with Docetaxel, Cisplatin and Capecitabine, Followed by Combined Cetuximab and Radiotherapy in Patients with Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck: A Phase I-II Study
    Perri, Francesco
    Muto, Paolo
    Argenone, Angela
    Ionna, Franco
    Longo, Francesco
    Fulciniti, Franco
    Sandomenico, Fabio
    Daponte, Antonio
    Caponigro, Francesco
    ONCOLOGY, 2013, 84 (04) : 251 - 254
  • [24] A phase I/II trial of gefitinib and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck
    Caponigro, Francesco
    Romano, Carmen
    Milano, Amalia
    Solla, Raffaele
    Franchin, Giovanni
    Adamo, Vincenzo
    Mari, Ettore
    Morrica, Brunello
    Pepe, Stefano
    ANTI-CANCER DRUGS, 2008, 19 (07) : 739 - 744
  • [25] Phase II study of 250 mg gefitinib in advanced squamous cell carcinoma of the head and neck (SCCHN).
    Kane, MA
    Cohen, E
    List, M
    Mehrotra, B
    Gustin, D
    Mauer, A
    Cella, D
    Vokes, E
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 509S - 509S
  • [26] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    Kim, J. G.
    Kim, D. H.
    Sohn, S. K.
    Baek, J. H.
    Chae, Y. S.
    Lee, K. B.
    Sohn, J. H.
    Park, J. S.
    Kim, J. C.
    Park, I. K.
    EJC SUPPLEMENTS, 2005, 3 (02): : 300 - 300
  • [27] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    J G Kim
    S K Sohn
    D H Kim
    J H Baek
    S B Jeon
    Y S Chae
    K B Lee
    J S Park
    J H Sohn
    J C Kim
    I K Park
    British Journal of Cancer, 2005, 93 : 1117 - 1121
  • [28] Phase II study of concurrent chemoradiotherapy with capecitabine and cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck
    Kim, JG
    Sohn, SK
    Kim, DH
    Baek, JH
    Jeon, SB
    Chae, YS
    Lee, KB
    Park, JS
    Sohn, JH
    Kim, JC
    Park, IK
    BRITISH JOURNAL OF CANCER, 2005, 93 (10) : 1117 - 1121
  • [29] A phase I study of metformin in combination with cisplatin and radiation in locally advanced head and neck squamous cell carcinoma.
    Wise-Draper, Trisha Michel
    Takiar, Vinita
    Mierzwa, Michelle Lynn
    Huth, Bradley Joseph
    Redmond, Kevin P.
    Barrett, William
    Qualtieri, Julianne
    Xie, Changchun
    Morris, John Charles
    Gutkind, J. Silvio
    Sadraei, Nooshin Hashemi
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [30] Phase I study of vandetanib with radiation therapy with or without cisplatin in locally advanced head and neck squamous cell carcinoma
    Papadimitrakopoulou, Vasiliki A.
    Frank, Steven J.
    Cohen, Ezra W.
    Hirsch, Fred R.
    Myers, Jeffrey N.
    Heymach, John V.
    Lin, Heather
    Tran, Hai T.
    Chen, Changhu R.
    Jimeno, Antonio
    Nedzi, Lucien
    Vasselli, Joseph R.
    Lowe, Elizabeth S.
    Raben, David
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 (03): : 439 - 447